Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Cardiotoxicity

etoposide has been researched along with Cardiotoxicity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Li, X; Li, ZY; Xu, GS1
Armstrong, L; Atwal, M; Austin, CA; Cowell, IG; Lee, DC; Lee, KC; Rowe, C; Swan, RL1
Farina, K; Kalac, M; Kim, S1
Bal, C; Gulbas, Z; Ozkan, HA1

Other Studies

4 other study(ies) available for etoposide and Cardiotoxicity

ArticleYear
A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity.
    Cells, 2021, 11-12, Volume: 10, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cardiotoxicity; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Etoposide; Humans; Rats; Topoisomerase II Inhibitors

2021
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
    Molecular pharmacology, 2019, Volume: 96, Issue:4

    Topics: Anthracyclines; Cardiotoxicity; Cell Line, Tumor; Cell Survival; DNA Adducts; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Induced Pluripotent Stem Cells; K562 Cells; Mitoxantrone; Myocytes, Cardiac; Topoisomerase II Inhibitors

2019
Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:4

    Topics: Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Vincristine

2021
Assessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2014, Volume: 50, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Cardiotoxicity; Cyclophosphamide; Etoposide; Female; Heart; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk; ROC Curve; Time Factors; Treatment Outcome; Young Adult

2014